Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             144 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of orbital myositis preceding the intestinal symptoms of Crohn's disease Bourikas, Leonidas A.
2010
3 p. 349-350
2 p.
artikel
2 A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease Sack, C.

3 p. 302-310
artikel
3 A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis Poole, Chris D.
2010
3 p. 275-282
8 p.
artikel
4 Adalimumab for recurrent orbital myositis in Crohn's disease: Report of a case with a 3-year follow-up Hernández-Garfella, María-Luisa
2011
3 p. 265-266
2 p.
artikel
5 A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease Miehsler, W.
2010
3 p. 221-256
36 p.
artikel
6 Adult-onset Still's disease preceding Crohn's disease Katsanos, Konstantinos H.
2013
3 p. e93-e98
nvt p.
artikel
7 Alimentary disorders in young females with irritable bowel syndrome or ulcerative procto-sigmoiditis: A preliminary report Della Valle, Nicola
2013
3 p. e112-e113
nvt p.
artikel
8 5-Aminosalicyclic acid induced multisystem disorders in the course of Crohn' s disease Akbal, Erdem
2010
3 p. 345-346
2 p.
artikel
9 An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial Connolly, Mark P.
2009
3 p. 168-174
7 p.
artikel
10 Angiopoietins in inflammation and their implication in the development of inflammatory bowel disease. A review Linares, Pablo M.
2014
3 p. 183-190
8 p.
artikel
11 An improved model of care for inflammatory bowel disease (IBD) Mikocka-Walus, Antonina
2013
3 p. e120-e121
nvt p.
artikel
12 An unusual case of severe colitis after colonoscopy Singh-Ranger, Gurpreet
2011
3 p. 267-268
2 p.
artikel
13 A patient with severe Crohn's colitis responds to Faecal Microbiota Transplantation Gordon, Hannah
2014
3 p. 256-257
2 p.
artikel
14 A rare cause of rectal bleeding masquerading as proctitis Chatu, Sukhdev
2013
3 p. e99-e102
nvt p.
artikel
15 Assessment of activity of Crohn's disease by Doppler sonography of superior mesenteric artery flow Karoui, Sami
2010
3 p. 334-340
7 p.
artikel
16 Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease Lakatos, Peter Laszlo
2010
3 p. 283-290
8 p.
artikel
17 Association of a Nkx2-3 polymorphism with Crohn's disease and expression of Nkx2-3 is up-regulated in B cell lines and intestinal tissues with Crohn's disease Yu, Wei
2009
3 p. 189-195
7 p.
artikel
18 Autoimmune hepatitis during infliximab therapy for Crohn's disease: A case report Doyle, Adam
2011
3 p. 253-255
3 p.
artikel
19 Autologous haematopoietic stem cell transplantation in a patient with refractory Crohn's disease Kountouras, Jannis
2011
3 p. 275-276
2 p.
artikel
20 Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection Quera, Rodrigo
2014
3 p. 252-253
2 p.
artikel
21 Bell's palsy in a patient receiving adalimumab for Crohn's disease Lu, Lucy Xi
2013
3 p. e115-
1 p.
artikel
22 Bowel sonography in occlusive Crohn's disease Rispo, Antonio
2008
3 p. 269-270
2 p.
artikel
23 Cap polyposis mistaken for Crohn's disease: Case report and review of literature Kini, Geogry P.
2013
3 p. e108-e111
nvt p.
artikel
24 CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-α and MMP-3 production in patients with inflammatory bowel disease Gordon, J.N.
2009
3 p. 175-182
8 p.
artikel
25 Cerebral thrombosis in inflammatory bowel disease: A report of four cases Houissa, Fatma
2011
3 p. 249-252
4 p.
artikel
26 Chicken pox infection in a three months old infant exposed in utero to Adalimumab Johnsson, Anna
2013
3 p. e116-e117
nvt p.
artikel
27 Clinical course of microscopic colitis in a single-center cohort study Calabrese, Carlo
2011
3 p. 218-221
4 p.
artikel
28 Clinical, endoscopic and histological remission in paediatric chronically active ulcerative colitis after prolonged treatment with selective granulocyte–monocyte adsorptive apheresis Martín-Carpi, Javier
2009
3 p. 216-217
2 p.
artikel
29 Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events Magro, Fernando
2010
3 p. 301-311
11 p.
artikel
30 Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis Navaneethan, Udayakumar

3 p. 330-336
artikel
31 Combined azithromycin and metronidazole therapy is effective in inducing remission in pediatric Crohn's disease Levine, Arie
2011
3 p. 222-226
5 p.
artikel
32 Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of life Probert, Christopher S.J.
2014
3 p. 200-207
8 p.
artikel
33 Communication of information to patients with inflammatory bowel disease: A European Collaborative Study in a multinational prospective inception cohort Politi, P.
2008
3 p. 226-232
7 p.
artikel
34 Complementary and alternative medicine in patients with inflammatory bowel disease: The results of a population-based inception cohort study (IBSEN) Opheim, Randi

3 p. 345-353
artikel
35 Concordance for IBD among twins compared to ordinary siblings — A Norwegian population-based study Bengtson, May-Bente
2010
3 p. 312-318
7 p.
artikel
36 Conflict of Interest Statements of the authors of the ECCO Consensus on Ulcerative Colitis 2008
3 p. 273-277
5 p.
artikel
37 Construction of an ileocolic neosphincter — Nipple valve anastomosis for prevention of postoperative recurrence of Crohn's disease in the neoterminal ileum after ileocecal or ileocolic resection. Bakkevold, Kåre E.
2009
3 p. 183-188
6 p.
artikel
38 Contents 2008
3 p. v-vi
nvt p.
artikel
39 Contents 2009
3 p. v-vi
nvt p.
artikel
40 Contents 2013
3 p. v-vi
nvt p.
artikel
41 Contents 2014
3 p. v-vi
nvt p.
artikel
42 Contrast-enhanced ultrasonography: Usefulness in the assessment of postoperative recurrence of Crohn's disease Paredes, José María
2013
3 p. 192-201
10 p.
artikel
43 Corrigendum to “The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Current Management” [J Crohn's & Colitis 4 (2010) 28–62] Dignass, Axel U.
2010
3 p. 353-
1 p.
artikel
44 Crohn's disease with pulmonary manifestations in children: 2 case reports and review of the literature Vadlamudi, Narendra B.
2013
3 p. e85-e92
nvt p.
artikel
45 Cutaneous vasculitis in Crohn's disease Limdi, J.K.
2010
3 p. 351-352
2 p.
artikel
46 Delphi consensus statement: Quality indicators for Inflammatory Bowel Disease Comprehensive Care Units Calvet, Xavier
2014
3 p. 240-251
12 p.
artikel
47 Disease severity in familial cases of IBD Andreu, M.
2014
3 p. 234-239
6 p.
artikel
48 EBV-associated plasmablastic lymphoma in a patient with Crohn's disease after adalimumab treatment Liu, Li
2013
3 p. e118-e119
nvt p.
artikel
49 ECCO position challenged by European drug regulators Kurki, Pekka
2014
3 p. 258-
1 p.
artikel
50 Ectopıc spleen presentıng as an abdomınal mass ın a patıent wıth Crohn's dısease Koçak, Erdem

3 p. 394-395
artikel
51 Efficacy and tolerability of oral budesonide in Japanese patients with active Crohn's disease: A multicentre, double-blind, randomized, parallel-group Phase II study Suzuki, Yasuo
2013
3 p. 239-247
9 p.
artikel
52 Efficacy of Infliximab treatment in patients with severe Fistulizing Hidradenitis Suppurativa Elkjaer, Margarita
2008
3 p. 241-245
5 p.
artikel
53 EMA response to ECCO position statement on biosimilars Danese, Silvio
2014
3 p. 259-
1 p.
artikel
54 Endoscopic ultrasound for perianal Crohn's disease: Disease and fistula characteristics, and impact on therapy Lahat, Adi

3 p. 311-316
artikel
55 Endoscopic vs ultrasonographic findings related to Crohn's Disease recurrence: A prospective longitudinal study at 3years Onali, S.
2010
3 p. 319-328
10 p.
artikel
56 Eosinophilic-Crohn overlap colitis and review of the literature Katsanos, Konstantinos H.
2011
3 p. 256-261
6 p.
artikel
57 Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids Bello, C.
2011
3 p. 196-202
7 p.
artikel
58 Exacerbation of Crohn's disease as paradoxical effect of infliximab Tursi, Antonio

3 p. 396
artikel
59 Fatal Colonic Perforation in a Pregnant with Behçet's Disease Cakal, Basak
2011
3 p. 273-274
2 p.
artikel
60 Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity Blumenstein, I.
2011
3 p. 203-210
8 p.
artikel
61 Fibromuscular dysplasia mimicking Crohn's disease over a period of 23years Dolak, W.

3 p. 354-357
artikel
62 Fistulating Crohn's disease in a patient with rheumatoid arthritis Stather, Philip
2010
3 p. 347-
1 p.
artikel
63 Gastrointestinal basidiobolomycosis in a child; an unusual fungal infection mimicking fistulising Crohn's disease Saadah, Omar I.

3 p. 368-372
artikel
64 Genital fistulas in female Crohn's disease patients. de la Poza, Gema

3 p. 276-280
artikel
65 Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever Uslu, Nuray
2010
3 p. 341-344
4 p.
artikel
66 Henoch Schonlein purpura mimicking Crohn's ileitis Yavuz, Alper
2011
3 p. 271-272
2 p.
artikel
67 High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patients Vavricka, Stephan R.
2014
3 p. 191-199
9 p.
artikel
68 High-definition endoscopic imaging with i-Scan for the detection and characterization of duodenal Crohn's disease Hundorfean, Gheorghe
2013
3 p. e122-e123
nvt p.
artikel
69 High prevalence of low bone mineral density in patients with Inflammatory Bowel Disease in the setting of a peripheral Dutch hospital Van Schaik, Fiona D.M.
2008
3 p. 208-213
6 p.
artikel
70 High smoking cessation rate in Crohn's disease patients after physician advice – The TABACROHN Study Nunes, Tiago
2013
3 p. 202-207
6 p.
artikel
71 Historical evolution of the management of severe ulcerative colitis Caprilli, Renzo
2008
3 p. 263-268
6 p.
artikel
72 Idiopathic myointimal hyperplasia of mesenteric veins and pneumatosis intestinalis: A previously unreported association García-Castellanos, Raquel
2011
3 p. 239-244
6 p.
artikel
73 Idiopathic pancreatitis in inflammatory bowel disease Garrido Gómez, Elena
2008
3 p. 237-240
4 p.
artikel
74 Impact of ileal pouch-anal anastomosis on the surgical outcome of orthotopic liver transplantation for primary sclerosing cholangitis Obusez, Emmanuel C.
2013
3 p. 230-238
9 p.
artikel
75 Incidence and clinical course of Crohn's disease during the first year — Results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005–2009 Sjöberg, Daniel
2014
3 p. 215-222
8 p.
artikel
76 Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease Dige, Anders
2013
3 p. 248-255
8 p.
artikel
77 Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis — A randomized, placebo-controlled, pilot study Singla, Vikas
2014
3 p. 208-214
7 p.
artikel
78 Inflammatory bowel disease and familial adenomatous polyposis Samadder, N. Jewel
2013
3 p. e103-e107
nvt p.
artikel
79 Infliximab administered with shortened infusion times in a specialized IBD infusion unit: A prospective cohort study Van Assche, Gert
2010
3 p. 329-333
5 p.
artikel
80 Infliximab and complications after colectomy in patients with ulcerative colitis Bregnbak, David

3 p. 281-286
artikel
81 Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease Hagihara, Yoshie
2014
3 p. 223-233
11 p.
artikel
82 Infliximab use in a patient with ulcerative colitis and alcoholic cirrhosis with portal hypertension Carrión, Silvia
2008
3 p. 271-272
2 p.
artikel
83 Instruction for Authors 2009
3 p. I-II
nvt p.
artikel
84 Instruction for Authors 2011
3 p. I-II
nvt p.
artikel
85 Instructions for Authors 2008
3 p. I-II
nvt p.
artikel
86 Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis Aratari, Annalisa
2011
3 p. 262-
1 p.
artikel
87 Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study Krishnaprasad, Krupa

3 p. 287-293
artikel
88 Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis Lee, Thomas W.

3 p. 267-275
artikel
89 Issue Content list 2010
3 p. v-vi
nvt p.
artikel
90 Issue Contents list
3 p. v-vi
artikel
91 Issue Contents List 2011
3 p. v-vi
nvt p.
artikel
92 Listeria monocytogenes bacteremia and CMV colitis in a patient with Ulcerative Colitis Santos-Antunes, João
2014
3 p. 254-255
2 p.
artikel
93 Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease Leung, Yvette
2009
3 p. 162-167
6 p.
artikel
94 Long-term outcome after infliximab for refractory ulcerative colitis Ferrante, Marc
2008
3 p. 219-225
7 p.
artikel
95 Magnetic resonance enteroclysis in patients with Crohn's disease: Fat saturated T2-weighted sequences for evaluation of inflammatory activity Grieser, Christian

3 p. 294-301
artikel
96 Medical and surgical therapy of inflammatory bowel disease in the elderly — Prospects and complications Stallmach, Andreas
2011
3 p. 177-188
12 p.
artikel
97 Microcarcinoids associated with diversion colitis in a patient with Crohn's disease Borralho, Paula
2008
3 p. 246-249
4 p.
artikel
98 Monster parastomal pyoderma gangrenosum effectively treated by topical tacrolimus Rispo, Antonio
2009
3 p. 218-219
2 p.
artikel
99 Much is still to be learned about pathogenic Mycobacteria Chamberlin, William M.

3 p. 390-391
artikel
100 Mycobacterium avium paratuberculosis and Crohn's Disease: An association requiring more research Kuenstner, J. Todd

3 p. 393
artikel
101 Nursing resources and responsibilities according to hospital organizational model for management of inflammatory bowel disease in Spain Marín, Laura
2011
3 p. 211-217
7 p.
artikel
102 Opportunistic infections and vaccinations in IBD patients Waters, Oliver
2011
3 p. 263-
1 p.
artikel
103 Oral locally active steroids in inflammatory bowel disease Nunes, Tiago
2013
3 p. 183-191
9 p.
artikel
104 Osteoporosis in inflammatory bowel disease Reinshagen, Max
2008
3 p. 202-207
6 p.
artikel
105 Pathogenic Escherichia coli in inflammatory bowel diseases Darfeuille-Michaud, Arlette
2008
3 p. 255-262
8 p.
artikel
106 Portal vein thrombosis in inflammatory bowel diseases: A single-center case series Maconi, Giovanni

3 p. 362-367
artikel
107 Prevalence and risk factors for colonic perforation during colonoscopy in hospitalized inflammatory bowel disease patients Navaneethan, Udayakumar
2011
3 p. 189-195
7 p.
artikel
108 Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD) Aguas, Mariam
2011
3 p. 227-233
7 p.
artikel
109 Public awareness of Crohn's disease and ulcerative colitis: A national survey Angelberger, Sieglinde
2009
3 p. 157-161
5 p.
artikel
110 Pulmonary and nodal tuberculosis in a patient with inflammatory bowel disease and HIV infection treated with infliximab Carrión, Sílvia
2009
3 p. 220-221
2 p.
artikel
111 Pulmonary Crohn's disease: A rare extra-intestinal manifestation treated with infliximab Pedersen, Natalia
2009
3 p. 207-211
5 p.
artikel
112 Reconsidering the methodology of “stress” research in inflammatory bowel disease Keefer, Laurie
2008
3 p. 193-201
9 p.
artikel
113 Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: An IG-IBD study Bertomoro, Perla
2010
3 p. 291-300
10 p.
artikel
114 Reply to Dr. Chiodini's and Dr. Chamberlin's letters Van Kruiningen, Herbert J.

3 p. 392
artikel
115 Reply to Drs. Waters and Ahmad Rahier, Jean-François
2011
3 p. 264-
1 p.
artikel
116 Response pattern recognition in paediatric Crohn's disease patients treated with enteral nutrition Nielsen, N. Kjaersgaard
2008
3 p. 233-236
4 p.
artikel
117 Results of the 2nd Scientific Workshop of the ECCO (III): Basic mechanisms of intestinal healing Rieder, Florian

3 p. 373-385
artikel
118 Reversible bilateral optic neuritis after Infliximab discontinuation in a patient with Crohn's disease Felekis, Taxiarchis
2009
3 p. 212-214
3 p.
artikel
119 Risk factors for inflammatory bowel diseases according to the “hygiene hypothesis”: A case–control, multi-centre, prospective study in Southern Italy Castiglione, Fabiana

3 p. 324-329
artikel
120 Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening Jauregui-Amezaga, Aranzazu
2013
3 p. 208-212
5 p.
artikel
121 Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents Domínguez, Jose
2008
3 p. 250-254
5 p.
artikel
122 Sjogren's syndrome in a patient with ulcerative colitis and primary sclerosing cholangitis: Case report and review of the literature Katsanos, Konstantinos H.
2009
3 p. 200-203
4 p.
artikel
123 Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease Schreiber, S.
2013
3 p. 213-221
9 p.
artikel
124 Successful treatment of eosinophilic colitis by montelukast sodium plus budesonide in a patient with Waldenstrom macroglobulinemia Ibis, Mehmet
2011
3 p. 277-278
2 p.
artikel
125 Suspension of smoking is a risk factor for Ulcerative Colitis (UC) diagnosed after an Acute Myocardial Infarction (AMI) de Leone, Annalisa
2009
3 p. 215-
1 p.
artikel
126 Synchronous colorectal carcinoma in segmental colitis associated with diverticulosis Tursi, Antonio

3 p. 386-387
artikel
127 Systemic amyloidosis in inflammatory bowel disease: Retrospective study on its prevalence, clinical presentation, and outcome Serra, Isabel
2010
3 p. 269-274
6 p.
artikel
128 The association of Haptoglobin polymorphism with Crohn's disease in Israel Maza, Itay
2008
3 p. 214-218
5 p.
artikel
129 The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD) Malik, S.

3 p. 337-344
artikel
130 The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD) Shim, Lisa
2011
3 p. 234-238
5 p.
artikel
131 The image of mass destruction inevitably leads to intellectual mass distraction Chiodini, R.J.

3 p. 388-389
artikel
132 The joint–gut axis in inflammatory bowel diseases Brakenhoff, Lianne K.P.M.
2010
3 p. 257-268
12 p.
artikel
133 The long journey of salicylates in ulcerative colitis: The past and the future Caprilli, Renzo
2009
3 p. 149-156
8 p.
artikel
134 Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31 Steenholdt, Casper

3 p. 358-361
artikel
135 The role of CMV in steroid-resistant ulcerative colitis: A systematic review Ayre, Karyn
2009
3 p. 141-148
8 p.
artikel
136 The role of granulocyte and monocyte apheresis in inflammatory bowel disease Yamamoto, Takayuki
2013
3 p. e114-
1 p.
artikel
137 The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China Li, Yue

3 p. 317-323
artikel
138 The successful treatment of IgG4-positive colitis with adalimumab in a patient with IgG4-related sclerosing disease – a new subtype of aggressive colitis? Naghibi, Mani
2013
3 p. e81-e84
nvt p.
artikel
139 Thiopurines, a previously unrecognised cause for fatigue in patients with inflammatory bowel disease Lee, Thomas W.T.
2009
3 p. 196-199
4 p.
artikel
140 Tissue factor exposing microparticles in inflammatory bowel disease Palkovits, Julia
2013
3 p. 222-229
8 p.
artikel
141 Transient menorrhagia without adalimumab discontinuation in a patient with Crohn's disease Katsanos, Konstantinos H.
2010
3 p. 348-
1 p.
artikel
142 Unusual perforation after balloon dilation in a Crohn's disease patient: Report of a case Mocciaro, Filippo
2011
3 p. 269-270
2 p.
artikel
143 Use of Infliximab as rescue therapy in acute severe Ulcerative Colitis with recent norovirus infection O'Connor, J.P.A.
2009
3 p. 204-206
3 p.
artikel
144 Xanthogranulomatous inflammation of ascending colon with mucosal involvement: Report of a first case Dhawan, Shashi
2011
3 p. 245-248
4 p.
artikel
                             144 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland